Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.460
+0.160 (6.96%)
At close: May 30, 2025, 4:00 PM
2.540
+0.080 (3.25%)
After-hours: May 30, 2025, 7:48 PM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $15.54 million as of May 30, 2025. Its market cap has decreased by -23.83% in one year.
Market Cap
15.54M
Enterprise Value
-2.30M
1-Year Change
-23.83%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $15.54M, a decrease of -91.91%. That is a compound annual growth rate of -44.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 14.53M | 192.96% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 648.68B |
| Johnson & Johnson | 369.52B |
| AbbVie | 327.88B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.48B |
| Abbott Laboratories | 231.14B |
| Novartis AG | 219.70B |
| AstraZeneca | 217.50B |